Compare Align Technology, Inc. (ALGN) vs Vanguard Value Index Fund ETF (VTV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Align Technology, Inc. vs Vanguard Value Index Fund ETF — how do they compare? Align Technology, Inc. trades at $181.11 (market cap $12.86B), while Vanguard Value Index Fund ETF trades at $219.99. The key difference: Vanguard Value Index Fund ETF is trading nearer its 52-week high, Align Technology, Inc. nearer its low. Which is the better fit depends on your goals.
| ALGN | VTV | |
|---|---|---|
Market Cap | $12.86B | — |
Sector | Health | — |
52-Week High | $207.19 | $220.51 |
52-Week Low | $124.88 | $175.51 |
Enterprise Value | $11.92B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
VTV (Vanguard Value ETF) trades at $219.20, up 0.29% with a bullish technical signal from moving averages. The ETF has gained 16% year-to-date and 27% over the past year, benefiting from investor rotation away from technology stocks toward value-oriented large caps. Recent news highlights VTV's defensive positioning with only 13% technology exposure and a focus on stable dividend-paying companies.
The outlook remains positive as value stocks continue their momentum amid AI sector concerns and potential Fed rate hikes. Key risks include macroeconomic sensitivity and sector rotation reversals. The ETF's low 0.03% expense ratio and higher dividend yield compared to broad market alternatives provide competitive advantages for long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About Vanguard Value Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the CRSP US Large Cap Value Index, a broadly diversified index predominantly made up of value stocks of large US companies. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VTV →
